Readnour Robin Shane Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$1.64M
Insider Sells Quantity
2
Insider Sells Sum
$111,671.98

Insider Activity of Readnour Robin Shane

According to the SEC Form 4 filings, Readnour Robin Shane, being in a position of

  1. director at AN2 Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 52629 shares for $316,700,
    over all time since 2022-03-29, has bought 417618 shares for $1.64M, and sold 57723 shares for $428,372.

Biography of Readnour Robin Shane

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $316,7004100

Comparison of Insiders on Amount of Buys and Sells

2026-09-09SaleAN2 Therapeutics, Inc.
ANTX
director
1,108
0.0032%
$6.02$6,675-15.71%
2026-09-08SaleAN2 Therapeutics, Inc.
ANTX
director
10,019
0.0225%
$6.02$60,297-19.23%
2026-09-03SaleAN2 Therapeutics, Inc.
ANTX
director
6,100
0.0139%
$6.07$37,026-18.66%
2026-08-17SaleAN2 Therapeutics, Inc.
ANTX
director
35,402
0.0829%
$6.01$212,702-11.87%
2024-12-10PurchaseAN2 Therapeutics, Inc.
ANTX
director
10,000
0.0329%
$1.49$14,930-21.85%
2024-12-09PurchaseAN2 Therapeutics, Inc.
ANTX
director
30,772
0.104%
$1.43$43,984-16.55%
2024-12-06PurchaseAN2 Therapeutics, Inc.
ANTX
director
19,228
0.0635%
$1.45$27,795-17.36%
2024-11-27PurchaseAN2 Therapeutics, Inc.
ANTX
director
50,000
0.142%
$1.42$70,840-12.41%
2024-11-26PurchaseAN2 Therapeutics, Inc.
ANTX
director
25,000
0.0698%
$1.39$34,845-13.67%
2024-11-20PurchaseAN2 Therapeutics, Inc.
ANTX
director
50,000
0.116%
$1.16$57,870-6.92%
2024-11-19PurchaseAN2 Therapeutics, Inc.
ANTX
director
150,000
0.3112%
$1.04$155,258+14.15%
2024-01-12SaleAN2 Therapeutics, Inc.
ANTX
director
1,425
0.0626%
$21.91$31,229-89.94%
2024-01-10SaleAN2 Therapeutics, Inc.
ANTX
director
3,669
0.1612%
$21.93$80,443-89.9%
2022-03-29PurchaseAN2 Therapeutics, Inc.
ANTX
82,618
2.4836%
$15.00$1.24M-24.72%
Total: 14
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.